Conagra (CAG) Q3 2026 Earnings Call Transcript

Management reported material cost hedges of ~60% for Q1 and ~40% for the full fiscal year (animal proteins only ~15%) and noted contracted line-haul limits freight exposure. Operating margin guidance was moved to the high end of the prior 11.0%–11.5% range and the free cash flow conversion target was raised from 100% to 105%; inventory on the balance sheet is $2.0B and Project Catalyst (AI) is being deployed to accelerate reductions. Ardent Mills equity earnings were pressured (roughly off $0.10) due to muted wheat trading, though cash dividends remain on plan. Management emphasized volume-driven momentum in frozen and snacks and encouraging elasticity after targeted pricing in canned/cocoa categories.

Analysis

Conagra’s headline guidance shifts mask a more important structural lever: balance-sheet-driven margin conversion. Project Catalyst and AI-enabled inventory optimization create a realistic runway to convert working capital into 100–300bps of sustainable margin expansion and $150–400m of incremental free cash flow over 12–24 months if execution matches management’s tone. That magnitude would re-rate a stock trading on single-turn multiple assumptions more than a near-term operating beat.

The principal near-term risk is animal-protein price volatility and the Ardent Mills trading book. With only ~15% protein coverage for fiscal ’27, a short, sharp protein shock (weeks to months) is the likeliest catalyst to reverse the quarter-to-quarter margin inflection; conversely, wheat/trading volatility is asymmetric — Ardent’s dividend insulates cash flow now, but equity earnings will remain noisy and can swing reported EPS by cents quickly. Freight is a medium-term wildcard: high contracted line-haul reduces sensitivity this year but creates rollover risk as spot > contract today and contracts re-price over the next 6–12 months.

Second-order winners include in-house protein processors and robotics/automation suppliers to food manufacturing; losers are pure-play co-packers and commodity trading desks with little recurring margin. The consensus underappreciates two timing effects: (1) a 53rd week and lower Q4 A&P are lumpy but predictable catalysts for near-term margin beats, and (2) structural FCF improvement from inventory reductions is multi-quarter and can surprise on the upside once AI-driven cadence stabilizes.

Key Decisions for Investors

• Directional: Buy CAG equity or equivalent notional via call spread (bull-call spread) — buy CAG 12-month 5% ITM / sell 12-month 25% OTM calls to cap upside — thesis: realize 100–200bps margin expansion + inventory cash release in 6–12 months. Risk: limited to net premium if using options; target 20–30% total return if catalysts land within 12 months.
• Hedged long (preferred): Acquire CAG stock and establish a 9–12 month collar — buy protective 8% OTM puts and sell 20% OTM calls to finance ~75% of put cost. This preserves upside to a clear margin recovery while limiting downside from a protein spike or tariff surprise; expected payoff: asymmetric upside capture with ~8% downside protection at cost-neutral to small debit.
• Tactical hedge: Buy short-dated (30–90 day) CAG put spreads as insurance against a protein-price shock or sudden tariff news — enter when commodities (live cattle/poultry) futures move +10% week-over-week or when headlines indicate tariff wrap >$40m. Cost small; acts as event insurance protecting near-term EPS volatility.
• Event-monitor: Maintain a small long position and add size on two signals — (A) AI inventory reductions show sequential working-capital release >$100m in a single quarter, or (B) evidence of chicken repatriation delivering >100bps gross-margin improvement in the following quarter. If neither occurs in 9–12 months, trim position and redeploy capital.